Kruppel-like factor 4 is a mediator of proinflammatory signaling in macrophages

Mark W Feinberg1, Zhuoxiao Cao, Akm Khyrul Wara

  • 1Program in Cardiovascular Transcriptional Biology, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. mfeinberg@rics.bwh.harvard.edu

Insights

Kruppel-like factor 4 (KLF4) regulates macrophage activation by balancing pro-inflammatory and anti-inflammatory signals. This study identifies KLF4 as a key mediator in chronic inflammatory diseases like atherosclerosis.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • Macrophage activation is crucial in chronic inflammatory diseases, including atherosclerosis.
  • Pro-inflammatory cytokines (interferon-gamma, lipopolysaccharide, tumor necrosis factor-alpha) promote activation, while anti-inflammatory factors (transforming growth factor-beta1) suppress it.
  • The molecular regulators balancing these opposing pathways are not fully understood.

Purpose of the Study:

  • To identify novel molecular mediators that regulate the balance between pro-inflammatory and anti-inflammatory signaling in macrophages.
  • To elucidate the role of Kruppel-like factor 4 (KLF4) in controlling macrophage activation pathways.

Main Methods:

  • Investigated KLF4 expression in response to various cytokines in macrophages.
  • Utilized gene overexpression and knockdown techniques to assess KLF4's functional impact on macrophage activation markers (inducible nitric-oxide synthase - iNOS) and cytokine signaling pathways (TGF-beta1/Smad3).
  • Analyzed KLF4's interaction with signaling proteins (p65/RelA, Smad3) and its effect on gene promoter activity (iNOS, plasminogen activator inhibitor-1 - PAI-1).

Main Results:

  • KLF4 expression is induced by pro-inflammatory stimuli (IFN-gamma, LPS, TNF-alpha) and suppressed by TGF-beta1.
  • KLF4 overexpression activates the iNOS promoter and inhibits the TGF-beta1/Smad3-mediated PAI-1 promoter.
  • KLF4 knockdown attenuates pro-inflammatory induction of iNOS and enhances TGF-beta1/Smad3 signaling.
  • KLF4 interacts with p65/RelA to induce the iNOS promoter and antagonizes Smad3 for p300/CBP to inhibit PAI-1 induction.

Conclusions:

  • KLF4 is a critical regulator of macrophage activation, integrating pro-inflammatory and anti-inflammatory signals.
  • KLF4 plays a significant role in pathways relevant to chronic inflammatory conditions like atherosclerosis.
  • KLF4's distinct mechanisms of action on iNOS and PAI-1 promoters highlight its complex regulatory function.

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...